Ignite Creation Date:
2025-12-26 @ 10:46 PM
Ignite Modification Date:
2025-12-26 @ 10:46 PM
Study NCT ID:
NCT01165112
Status:
COMPLETED
Last Update Posted:
2018-12-05
First Post:
2010-06-21
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Bendamustine Hydrochloride, Rituximab, Etoposide, and Carboplatin in Treating Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma or Hodgkin Lymphoma
Sponsor:
University of Washington
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2010-09
Start Date Type:
ACTUAL
Primary Completion Date:
2015-06
Primary Completion Date Type:
ACTUAL
Completion Date:
2015-06
Completion Date Type:
ACTUAL
First Submit Date:
2010-06-21
First Submit QC Date:
None
Study First Post Date:
2010-07-19
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-04-17
Results First Submit QC Date:
None
Results First Post Date:
2017-05-25
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-11-09
Last Update Post Date:
2018-12-05
Last Update Post Date Type:
ACTUAL